Volume 122, Issue 2, Pages (February 2002)

Slides:



Advertisements
Similar presentations
Volume 131, Issue 1, Pages (July 2006)
Advertisements

Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma  Ya-Wei Qiang, Bart.
Volume 56, Issue 5, Pages (November 1999)
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Nan-Hyung Kim, Ai-Young Lee  Journal of Investigative Dermatology 
Platelet-Derived Growth Factor-BB Mediates Cell Migration through Induction of Activating Transcription Factor 4 and Tenascin-C  Kristine P. Malabanan,
Connective Tissue Growth Factor (CCN2) in Rat Pancreatic Stellate Cell Function: Integrin α5β1 as a Novel CCN2 Receptor  Runping Gao, David R. Brigstock 
Volume 114, Issue 4, Pages (April 1998)
Volume 123, Issue 1, Pages (July 2002)
High molecular weight hyaluronic acid regulates osteoclast formation by inhibiting receptor activator of NF-κB ligand through Rho kinase  W. Ariyoshi,
Integrin dependent protein tyrosine phosphorylation is a key regulatory event in collagen IV mediated adhesion and proliferation of human lung tumor cell.
Volume 131, Issue 1, Pages (July 2006)
Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells
Roles of the cytoplasmic domains of the α and β subunits of human granulocyte- macrophage colony-stimulating factor receptor  Akihiko Muto, PhDa, Sumiko.
Volume 122, Issue 3, Pages (March 2002)
Volume 66, Issue 4, Pages (October 2004)
Differential effects of tumor necrosis factor-α and interleukin-1β on cell death in human articular chondrocytes  B. Caramés, Ph.D., M.J. López-Armada,
Signal transduction pathways triggered by the FcϵRIIb receptor (CD23) in human monocytes lead to nuclear factor-κB activation  Rosa M. Ten, MD, PhDa,
Richard T. Ethridge, Mark R. Hellmich, Raymond N. DuBois, B.Mark Evers 
PTF1α/p48 and cell proliferation
Resistin decreases insulin-like growth factor I–induced steroid production and insulin- like growth factor I receptor signaling in human granulosa cells 
Volume 118, Issue 4, Pages (April 2000)
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells  Guillermo Villegas, Bäerbel Lange-Sperandio,
Volume 114, Issue 4, Pages (April 1998)
Volume 11, Issue 2, Pages (February 2005)
Volume 16, Issue 4, Pages (October 2009)
Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo  Markus Wagner, Martha E. Lopez, Mitch.
Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation1  Dr Xiong Z. Ruan, Zac Varghese, Stephen.
Laminin γ2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells
The C-terminus of Hsp70-Interacting Protein Promotes Met Receptor Degradation  Kang Won Jang, PhD, Jeong Eun Lee, MD, Sun Young Kim, MD, Min-Woong Kang,
Volume 129, Issue 2, Pages (August 2005)
Volume 62, Issue 4, Pages (October 2002)
Volume 56, Issue 5, Pages (November 1999)
Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung.
Loss of Raf Kinase Inhibitor Protein Promotes Cell Proliferation and Migration of Human Hepatoma Cells  Han Chu Lee, Bo Tian, John M. Sedivy, Jack R.
Volume 68, Issue 3, Pages (September 2005)
Volume 87, Issue 2, Pages (February 2015)
Volume 119, Issue 3, Pages (September 2000)
Volume 68, Issue 1, Pages (July 2005)
Volume 115, Issue 2, Pages (August 1998)
An oncogenic role of sphingosine kinase
Volume 120, Issue 5, Pages (April 2001)
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Volume 117, Issue 3, Pages (September 1999)
Evidence for two distinct pathways in TNFα-induced membrane and soluble forms of ICAM-1 in human osteoblast-like cells isolated from osteoarthritic patients 
Volume 68, Issue 1, Pages (July 2005)
Evidence for low-density lipoprotein–induced expression of connective tissue growth factor in mesangial cells  Mimi Sohn, Yan Tan, Richard L. Klein, Ayad.
Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells  Jan-Michel Otte, Elke Cario, Daniel K.
Volume 122, Issue 3, Pages (March 2002)
Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor  L.D. Alexander, Y. Ding, S. Alagarsamy,
The Glutamate Release Inhibitor Riluzole Decreases Migration, Invasion, and Proliferation of Melanoma Cells  Maithao N. Le, Joseph L.-K. Chan, Stephen.
Volume 125, Issue 1, Pages (July 2003)
Volume 119, Issue 1, Pages (July 2000)
Upregulation of Tenascin-C Expression by IL-13 in Human Dermal Fibroblasts via the Phosphoinositide 3-kinase/Akt and the Protein Kinase C Signaling Pathways 
Volume 122, Issue 2, Pages (February 2002)
Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor  Dai Iwakiri, Daniel K. Podolsky 
Connective Tissue Growth Factor (CCN2) in Rat Pancreatic Stellate Cell Function: Integrin α5β1 as a Novel CCN2 Receptor  Runping Gao, David R. Brigstock 
Volume 65, Issue 5, Pages (May 2004)
Volume 116, Issue 6, Pages (June 1999)
Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells  Jeffrey A. Brockman, Rajnish A. Gupta, Raymond.
Roles of the cytoplasmic domains of the α and β subunits of human granulocyte- macrophage colony-stimulating factor receptor  Akihiko Muto, PhDa, Sumiko.
Volume 118, Issue 1, Pages (January 2000)
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Volume 119, Issue 1, Pages (July 2000)
Collagen Synthesis Is Suppressed in Dermal Fibroblasts by the Human Antimicrobial Peptide LL-37  Hyun Jeong Park, Dae Ho Cho, Hee Jung Kim, Jun Young.
Volume 122, Issue 1, Pages (January 2002)
Volume 68, Issue 2, Pages (August 2005)
Inhibition of the Epidermal Growth Factor Receptor Suppresses Telomerase Activity in HSC-1 Human Cutaneous Squamous Cell Carcinoma Cells  Arief Budiyanto,
Volume 56, Issue 6, Pages (December 1999)
Effects of Hepatocyte Growth Factor on the Expression of Type I Collagen and Matrix Metalloproteinase-1 in Normal and Scleroderma Dermal Fibroblasts 
Presentation transcript:

Volume 122, Issue 2, Pages 331-339 (February 2002) Tumor necrosis factor α stimulates invasion of Src-activated intestinal cells  Naoki Kawai, Shingo Tsuji, Masahiko Tsujii, Toshifumi Ito, Masakazu Yasumaru, Yoshimi Kakiuchi, Arata Kimura, Masato Komori, Yutaka Sasaki, Norio Hayashi, Sunao Kawano, Raymond Dubois, Masatsugu Hori  Gastroenterology  Volume 122, Issue 2, Pages 331-339 (February 2002) DOI: 10.1053/gast.2002.31023 Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 1 Phenotypes of RIE transfectants. (A) Morphologic features of RIE-m, RIE-ras, and RIE-src cells. (B) The protein levels of Ras and Src. The cells were cultured on the plastic plates in DMEM/1% FCS for 24 hours. (C) Response of RIE-src cells to TNF-α in the presence or absence of PDTC and herbimycin A. RIE-src cells cultured on plastic plates were treated as described in Materials and Methods. The bar represents 100 μm (magnification, 100×). Gastroenterology 2002 122, 331-339DOI: (10.1053/gast.2002.31023) Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 2 Colonies of RIE-ras and RIE-src cells in soft agar. Vehicle or TNF-α (40 ng/mL) treatment was started 2 days after cells were embedded in soft agar. The pictures were taken on day 7. (A) RIE-ras control, (B) RIE-ras treated with TNF-α, (C) RIE-src control, (D) RIE-src treated with TNF-α. Gastroenterology 2002 122, 331-339DOI: (10.1053/gast.2002.31023) Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 3 Comparison in sizes of colonies of RIE-ras and RIE-src cells in soft agar. The cells were cultured in soft agar in the presence of vehicle or TNF-α for 7 days, and then the longest diameters were measured. PDTC, herbimycin A, a Src-specific inhibitor, or AFC, a ras inhibitor, was added with TNF-α. These figures are the representative of 5 independent experiments. *P < 0.01 compared with nontreated value, **P < 0.01 compared with TNF-α–treated value. Gastroenterology 2002 122, 331-339DOI: (10.1053/gast.2002.31023) Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 4 Activation of Src TK. (A) Status of tyrosine phosphorylation of Src. Cells were pretreated for 1 hour with PDTC (10 μmol/L) or herbimycin A (0.5 μg/mL), then treated for 3 hours with vehicle or TNF-α, and harvested. Src was precipitated from the cell lysates (400 μg) by use of anti-Src antibody, and tyrosine phosphorylation and Src protein were detected by immunoblot analysis. (B) Activity of Src protein tyrosine kinase. c-Src immunoprecipitates were collected the same as above. Protein tyrosine kinase activity was measured by enzyme-linked immunosorbent assay. These figures are the representative of 5 independent experiments. *P < 0.01 compared with nontreated value, **P < 0.01 compared with TNF-α–treated value. Gastroenterology 2002 122, 331-339DOI: (10.1053/gast.2002.31023) Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 5 FACS showing peroxide levels in RIE-ras and RIE-src cells treated with TNF-α. After staining with DCFH-DA, the cells were treated with TNF-α for 1 hour. Pretreatment with PDTC preceded TNF-α treatment by 1 hour. Intracellular peroxide level was estimated by FACS. Panels A, B, and C represent RIE-m, RIE-ras, and RIE-src cells, respectively. Lines indicate as below: (a) the control, (b) TNF-α–treated, and (c) PDTC-pretreated groups. In RIE-m cells, line (c) was overlapped with (a). Gastroenterology 2002 122, 331-339DOI: (10.1053/gast.2002.31023) Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 6 Regulation of E-cadherin expression and tyrosine phosphorylation of β-catenin and E-cadherin. Cells were incubated in DMEM/1% FCS in the presence or absence of vehicle or TNF-α for 8 hours. Pretreatment with PDTC or herbimycin A preceded TNF-α treatment by 1 hour. (A) Comparison of E-cadherin expression among RIE transfectants. Whole cell lysates (20 μg) were resolved by sodium dodecyl sulfate–polyacrylamide gel electrophoresis, and E-cadherin protein was detected by anti–E-cadherin antibody. The same blot was stained with Coomasie brilliant blue. (B) mRNA level of E-cadherin. Total RNA was prepared from the cells treated with vehicle or TNF-α for 5 hours, and E-cadherin mRNA level was detected by RT-PCR analysis. (C) Status of tyrosine phosphorylation of β-catenin and E-cadherin. Whole cell lysates (400 μg) associated with E-cadherin were collected by immunoprecipitation using anti–E-cadherin antibody and subjected to immunoblot analysis by use of anti-phosphotyrosine or β-catenin antibody. Gastroenterology 2002 122, 331-339DOI: (10.1053/gast.2002.31023) Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 7 Comparison of motility of RIE transfectants. Cells were suspended in DMEM/0.1% bovine serum albumin, plated on Boyden chamber inserts (pore size 8 μm) with vehicle or TNF-α, and incubated for 8 hours. In the bottom chambers, laminin (50 μg/mL) was added as a chemoattractant. PDTC, herbimycin A, AFC, or TGF-α was added to the inserts 1 hour before TNF-α treatment. These figures are the representative of 5 independent experiments. *P < 0.01 compared with nontreated value, **P < 0.01 compared with TNF-α–treated value. Gastroenterology 2002 122, 331-339DOI: (10.1053/gast.2002.31023) Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 8 Comparison of invasion among RIE transformants. Cells were incubated on the Matrigel matrix loaded on the invasion chamber inserts for 10 hours, and the medium in the insert and the bottom chamber was replaced with DMEM/1% FCS and vehicle or TNF-α. The assays were started with addition of hepatocyte growth factor (20 ng/mL) in the bottom chamber and incubated for 24 hours. The numbers of cells that invaded through the filters of inserts were counted. PDTC, herbimycin A, AFC, or TGF-α was added 1 hour before TNF-α treatment. These figures are the representative of 4 independent experiments. *P < 0.01 compared with nontreated value, **P < 0.01 compared with TNF-α–treated value. Gastroenterology 2002 122, 331-339DOI: (10.1053/gast.2002.31023) Copyright © 2002 American Gastroenterological Association Terms and Conditions